Compare AGRZ & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AGRZ | POM |
|---|---|---|
| Founded | 2020 | 2015 |
| Country | Malaysia | China |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Other Specialty Stores |
| Sector | Consumer Staples | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9M | 6.5M |
| IPO Year | 2024 | 2021 |
| Metric | AGRZ | POM |
|---|---|---|
| Price | $0.22 | $0.69 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 5.1M | 32.7K |
| Earning Date | 05-11-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $4.15 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.17 | $0.06 |
| 52 Week High | $7.20 | $6.43 |
| Indicator | AGRZ | POM |
|---|---|---|
| Relative Strength Index (RSI) | 39.46 | 35.71 |
| Support Level | $0.18 | $0.63 |
| Resistance Level | $0.46 | $1.17 |
| Average True Range (ATR) | 0.03 | 0.10 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 16.72 | 15.05 |
Agroz Inc is a vertically integrated agricultural technology (AgTech) company focused on designing, innovating, developing, building, operating and managing large, commercial-scale, industrial-grade indoor CEA vertical farms using CEA practices. Its mission is to improve food safety, food security, and sustainability for society by creating a reliable, accessible food supply through its AgTech products and services. CEA vertical farming is an agricultural method involving crop cultivation through vertically stacked layers in a controlled indoor environment. CEA practices are defined by growing produce in spaces where environmental conditions can be controlled and manipulated to match the needs of specific plants.
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of its revenue is derived from the Pharmaceutical supply chain segment.